Literature DB >> 31642795

Combined Ischemic Preconditioning and Resveratrol Improved Bloodbrain Barrier Breakdown via Hippo/YAP/TAZ Signaling Pathway.

Ganji Hong1, Ying Yan2, Yali Zhong3, Jianer Chen4, Fei Tong5,6,7, Qilin Ma1.   

Abstract

BACKGROUND: Transient Ischemia/Reperfusion (I/R) is the main reason for brain injury and results in disruption of the Blood-Brain Barrier (BBB). It had been reported that BBB injury is one of the main risk factors for early death in patients with cerebral ischemia. Numerous investigations focus on the study of BBB injury which have been carried out.
OBJECTIVE: The objective of this study was to investigate the treatment function of the activation of the Hippo/Yes-Associated Protein (YAP) signaling pathway by combined Ischemic Preconditioning (IPC) and resveratrol (RES) before brain Ischemia/Reperfusion (BI/R) improves Blood-Brain Barrier (BBB) disruption in rats.
METHODS: Sprague-Dawley (SD) rats were pretreated with 20 mg/kg RES and IPC and then subjected to 2 h of ischemia and 22 h of reperfusion. The cerebral tissues were collected; the cerebral infarct volume was determined; the Evans Blue (EB) level, the brain Water Content (BWC), and apoptosis were assessed; and the expressions of YAP and TAZ were investigated in cerebral tissues.
RESULTS: Both IPC and RES preconditioning reduced the cerebral infarct size, improved BBB permeability, lessened apoptosis, and upregulated expressions of YAP and transcriptional co-activator with PDZ-binding motif (TAZ) compared to the Ischemia/Reperfusion (I/R) group, while combined IPC and RES significantly enhanced this action.
CONCLUSION: combined ischemic preconditioning and resveratrol improved blood-brain barrier breakdown via Hippo/YAP/TAZ signaling pathway. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Blood-Brain Barrier (BBB); Brain Ischemia/Reperfusion Injury (BI/RI); Brain Water Content (BWC); Hippo/YAP/TAZ; Ischemic Preconditioning (IPC); Resveratrol (RES).

Year:  2019        PMID: 31642795     DOI: 10.2174/1871527318666191021144126

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  2 in total

1.  FoxO4 negatively modulates USP10 transcription to aggravate the apoptosis and oxidative stress of hypoxia/reoxygenation-induced cardiomyocytes by regulating the Hippo/YAP pathway.

Authors:  Jingwen Huang; Yu Liu; Mei Wang; Rong Wang; Huifen Ling; Yan Yang
Journal:  J Bioenerg Biomembr       Date:  2021-07-12       Impact factor: 2.945

Review 2.  The Plant-Derived Compound Resveratrol in Brain Cancer: A Review.

Authors:  Terezia Kiskova; Peter Kubatka; Dietrich Büsselberg; Monika Kassayova
Journal:  Biomolecules       Date:  2020-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.